Showing results (61-70 of 66) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
International Journal of Clinical Oncology|April 12, 2020
Serum LOX-1 is a novel prognostic biomarker of colorectal cancerChiyo Nakashima-Nakasuga, Shoichi Hazama, Nobuaki Suzuki, et al.Anticancer Research|October 1, 2021
Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 ImmunotherapyKazuyuki Hamada, Kiyoshi Yoshimura, Yuya Hirasawa, et al.Cancer Immunology, Immunotherapy : CII|March 29, 2020
A phase I study of multi-HLA-binding peptides derived from heat shock protein 70/glypican-3 and a novel combination adjuvant of hLAG-3Ig and Poly-ICLC for patients with metastatic gastrointestinal cancers: YNP01 trialMasao Nakajima, Shoichi Hazama, Koji Tamada, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2023
Double cancer of primary hepatic angiosarcoma and hepatocellular carcinoma treated with atezolizumab plus bevacizumabYurika Yamauchi, Issei Saeki, Takahiro Yamasaki, et al.Oncology Letters|February 3, 2018
Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomyRyoji Kamei, Kiyoshi Yoshimura, Shigefumi Yoshino, et al.Oncology Letters|November 26, 2020
Siglec-7 is a predictive biomarker for the efficacy of cancer vaccination against metastatic colorectal cancerKensuke Yamada, Shoichi Hazama, Nobuaki Suzuki, et al.Pageof 7